Gabelli Funds LLC Cuts Stake in Cigna Group $CI

Gabelli Funds LLC reduced its stake in shares of Cigna Group (NYSE:CI) by 22.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,420 shares of the health services provider’s stock after selling 14,200 shares during the period. Gabelli Funds LLC’s holdings in Cigna Group were worth $13,877,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of Cigna Group by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after acquiring an additional 414,834 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in shares of Cigna Group by 8.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after acquiring an additional 903,334 shares during the period. Dodge & Cox lifted its holdings in shares of Cigna Group by 4.0% during the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock worth $2,682,231,000 after acquiring an additional 354,615 shares during the period. Sanders Capital LLC lifted its holdings in shares of Cigna Group by 0.5% during the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after acquiring an additional 35,150 shares during the period. Finally, Capital Research Global Investors lifted its holdings in shares of Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after acquiring an additional 1,855,897 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 205,904 shares of company stock valued at $60,277,068. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

CI has been the subject of a number of research analyst reports. Sanford C. Bernstein increased their target price on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 5th. Raymond James Financial set a $340.00 target price on shares of Cigna Group in a research report on Friday, May 1st. Guggenheim increased their target price on shares of Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Robert W. Baird set a $337.00 target price on shares of Cigna Group in a research report on Friday, May 1st. Finally, Royal Bank Of Canada increased their target price on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $338.35.

Cigna Group Stock Up 1.6%

CI stock opened at $291.37 on Wednesday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $77.08 billion, a P/E ratio of 12.35, a PEG ratio of 1.00 and a beta of 0.30. The firm has a 50 day simple moving average of $275.45 and a 200-day simple moving average of $275.51.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same quarter last year, the company earned $6.74 earnings per share. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts predict that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.